Congratulations to SDEE members Reveal Biosciences and Explora BioLabs on receiving a National Institute on Aging (NIA) contract to to develop and maintain an Aged Rodent Tissue Bank. This is a prestigious contract award from the NIA, a National Institutes of Health agency supporting research on aging and Alzheimer's disease research.
“We are excited to build upon our strong relationship with Explora BioLabs and combine our expertise to develop and maintain the Aged Rodent Tissue Bank. This tissue source has become a game-changing tool for research on aging, as investigators are no longer required to wait months or years to study their tissue of interest, significantly accelerating their research,” said Dr. Claire Weston, CEO and founder of Reveal Biosciences.
Reveal Biosciences is a leading San Diego-based CRO specializing in Advanced Tissue Technologies such as IHC, ISH, digital pathology & biomarker quantification.
Explora BioLabs is a San Diego-based preclinical CRO that provides discovery pharmacology and contract vivarium services to the biotech, pharmaceutical and academic communities.
Flow Paradigm and its subsidiaries, nanoBioforms and FloCyte recently announced they are moving to a new facility in San Diego. "This move gives us greater access to companion technologies which provides more value to our clients. Work will not stop during the move, so keep the experiments coming." - Dana Buckman, CEO at Flow Paradigm, nanoBioforms & FloCyte.
Flow Paradigm is a full service flow cytometry contract research organization with services ranging from antibody characterization to assay development.
ThermoForma 3860 CO2 incubator
Nuaire Labgard 6' TC hood
VWR Symphony pH meter with 2 probes
Barnstead Nanopure Diamond ultra-purification water system
Thermo Smartpure ultra-purification water system
Beckman Microfuge 18
Thermolyne Cimarec3 magnetic stir plate with heat element
Sterilaire UV lamp
If interested please contact Rob at 310-926-6159 or email at firstname.lastname@example.org
Congratulations to Reveal Biosciences, LLC on their continued success in the San Diego community. Founder and CEO, Claire Weston PhD first bootstrapped the company in 2012 after she "identified a strong need for a high quality contract research organization focusing on tissue-based research". Reveal Biosciences has grown quickly since then, recently announcing a partnership agreement with Affymetrix, Inc.
About Reveal Biosciences
Reveal Biosciences is a leading provider of advanced tissue technology services and tissue-based research. The company’s portfolio includes in situ hybridization (ISH), immunohistochemistry (IHC), immunofluorescence (IF), and histology. Reveal enhances these services with proprietary technologies for NGPx™ Next Generation Pathology, multiplexing, whole-slide imaging, and ImageDx™ image analysis software as a service. They are now located at 6760 Top Gun St. Ste. 110, San Diego, CA 92121.
Charles River Laboratories announced on January 7, 2016 the signing of a definitive agreement to acquire WIL Research. This acquisition will "enhance Charles River’s global footprint, scientific capabilities, and access to growing end markets, which provides a compelling value proposition for both clients and shareholders".
Charles River Laboratories is an early stage contract research organization (CRO) that provides essential products and services to help pharmaceutical and biotechnology companies, and academic institutions around the globe accelerate their research and drug development efforts.
Reveal Biosciences announced a partnership agreement with Affymetrix that will enable Reveal to offer new RNA biomarker validation services. Reveal will use Affymetrix ViewRNA ISH products combined with their proprietary ImageDx software to provide RNA in situ hybridization (ISH) staining, imaging and quantification services.
“We are thrilled to partner with Affymetrix to provide high-quality services using ViewRNA products. Our scientific expertise, combined with high-resolution imaging and our proprietary image analysis software, ImageDx™, form a powerful platform for the localization and quantification of mRNA in tissue samples,” said Dr. Claire Weston, CEO and founder of Reveal Biosciences. “This highly sensitive technology is changing the face of mRNA biomarker screening and analysis for translational research and diagnostics.”Read more
Congratulations to Scott Struthers and his team. Here is a link to the Xconomy article
October 06, 2015 11:25 AM Eastern Daylight Time
SAN DIEGO--(BUSINESS WIRE)--Allele Biotechnology & Pharmaceuticals, Inc. (“Allele”), a leader in the development of specialized cells for regenerative medicine and pharmaceutical drug discovery, today announced plans to form a commercial business for the banking of human induced pluripotent stem cells (iPSCs) by private individuals.
Join friends and colleagues for snacks and drinks as we celebrate the grand opening of our new research facility, vivarium and headquarters. This state-of-the-art vivarium is our fourth in San Diego, and will serve the expanding needs of our preclinical research clients. Tours of the laboratory and vivarium will be offered during the event, or please contact us anytime for a private showing.
Date and Time: Friday September 25, from 4-6pm
Address: 11175 Flintkote Ave, San Diego 92121.
Molecular Diagnostics Consulting is pleased to sponsor this expert panel discussion on digital health applications for disaster and remote healthcare settings Saving Lives with Connected Devices - Diagnostics Going Digital & Remote. This event is designed for entrepreneurs and start-ups interested in digital health monitoring & diagnostics.